Use of C2-substituted indan-1-one systems for preparing...

Details Use of C2-substituted indan-1-one systems for preparing... Use of C2-substituted indan-1-one systems for preparing...

2005-09-20

2005-09-20

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ketone doai

C514S601000, C514S613000, C514S675000, C514S681000, C514S706000, C514S381000, C514S396000, C514S383000, C514S438000, C514S461000, C514S247000, C514S374000, C514S378000, C514S372000

Reexamination Certificate

active

06946492

ABSTRACT:
Embodiments of the invention relate to methods of reducing weight in mammals and for the prophylaxis or treatment of obesity comprising administration of C2-substituted indan-1-one systems and their physiologically acceptable salts and physiologically functional derivatives. Compounds for use in methods of embodiments of the invention may include compounds of the formulain which the radicals are as defined, and their physiologically acceptable salts.

REFERENCES:
patent: 0 009 554 (1980-04-01), None
patent: 0 313 296 (1989-04-01), None
patent: WO97/20806 (1997-06-01), None
patent: WO97/26265 (1997-07-01), None
patent: WO97/41097 (1997-11-01), None
patent: WO98/08871 (1998-03-01), None
patent: WO99/03861 (1999-01-01), None
patent: WO00/51971 (2000-09-01), None
patent: WO01/02373 (2001-01-01), None
patent: WO01/12176 (2001-02-01), None
C. Rufer et al., “Nichtsteroidale Entzündungshemmer. 8. (*) Entzündungshemmende Methansulfonanilide III.”, Eur. J. Med. Chem.—Chem. Ther., vol. 8, No. 2, pp. 173-180, (1982).
D. Seebach, et al., “Herstellung α-Thiolierter Carbonylverbindungen”, Chem. Ber., vol. 109, pp. 1601-1616, (1976).
H.J. Monteiro et al., “A New Synthesis of β-Keto-Phenylsulfoxides”, Tetrahedron Letters, No. 11, pp. 921-924, (1975).
A. K. Maiti et al., “Polyethylene glycol (PEG) 4000 Catalysed Regioselective Nucleophilic Ring Opening of Oxiranes—A new and Convenient Synthesis of β-Hydroxy Sulfone and βHydroxy Sulfide”, Tetrahedron, vol. 50, No. 35, pp. 10483-10490, (1994).
P. Tyle, “Iontophoretic Devices for Drug Delivery”, Pharmaceutical Research, vol. 3, No. 6, pp. 318-326, (1986).
P.D. Lambert et al., “Ciliary Neurotrophic Factor Activates Leptin-Like Pathways and Reduces Body Fat, Without Cachexia or Rebound Weight Gain, Even in Leptin-Resistant Obesity”, PNAS, vol. 98, No. 8, pp. 4652-4657 , (Apr. 2001).
C.G. Venier et al., “Peroxytrifluoroacetic Acid. A Convenient Reagent for the Preparation of Sulfoxides and Sulfones”, J. Org. Chem. vol. 47, pp. 3773-3774, (1982).

Affiliated with

Also associated with

Rating

Use of C2-substituted indan-1-one systems for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of C2-substituted indan-1-one systems for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of C2-substituted indan-1-one systems for preparing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3395983